Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 4, 2011, Pages 1104-1111

  Matsuo, Yukinori ^a   Shibuya, Keiko ^a   Nagata, Yasushi ^b   Takayama, Kenji ^a   Norihisa, Yoshiki ^a   Mizowaki, Takashi ^a   Narabayashi, Masaru ^a   Sakanaka, Katsuyuki ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Lung cancer; Prognostic factor; SBRT

Indexed keywords

CLASS I; CLASS II; CLINICAL OUTCOME; CUMULATIVE INCIDENCE; DISEASE PROGRESSION; LUNG CANCER; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; OVERALL TREATMENT TIME; PERFORMANCE STATUS; PROGNOSTIC FACTOR; PROGNOSTIC FACTORS; PROGNOSTIC MODEL; PROPORTIONAL HAZARDS MODEL; RECURSIVE PARTITIONING ANALYSIS; SBRT; SIGNIFICANT FACTORS; STEREOTACTIC BODY RADIOTHERAPY;

BIOLOGICAL ORGANS; MULTIVARIANT ANALYSIS; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

DISEASES;

DIURETIC AGENT; STEROID;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; DERMATITIS; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PARTITION COEFFICIENT; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; SEX FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77956113870     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.022     Document Type: Article

References (38)

1. H. Kato, T. Sobue, and K. Katanoda Cancer statistics in Japan 2008 2008 Foundation for Promotion of Cancer Research Tokyo
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. W.J. Scott, J. Howington, and S. Feigenberg Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 234S 242S (Pubitemid 47502810)
4. G.S. Sibley Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses - a review Cancer 82 1998 433 438 (Pubitemid 28112979)
5. H. Blomgren, I. Lax, and I. Näslund Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients Acta Oncol 34 1995 861 870
6. M. Uematsu, A. Shioda, and K. Tahara Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience Cancer 82 1998 1062 1070 (Pubitemid 28136518)
7. Y. Nagata, Y. Negoro, and T. Aoki Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame Int J Radiat Oncol Biol Phys 52 2002 1041 1046 (Pubitemid 34219025)
8. R. Onimaru, H. Shirato, and S. Shimizu Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135 (Pubitemid 36403684)
9. R. Timmerman, L. Papiez, and R. McGarry Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955 (Pubitemid 37433596)
10. J. Wulf, U. Haedinger, and U. Oppitz Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 60 2004 186 196 (Pubitemid 39165484)
11. Y. Nagata, M. Hiraoka, and T. Mizowaki Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group Int J Radiat Oncol Biol Phys 75 2009 343 347
12. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
13. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer: A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795 (Pubitemid 44423123)
14. R. Rami-Porta, D. Ball, and J. Crowley The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593 602 (Pubitemid 47171780)
15. K. Takayama, Y. Nagata, and Y. Negoro Treatment planning of stereotactic radiotherapy for solitary lung tumor Int J Radiat Oncol Biol Phys 61 2005 1565 1571 (Pubitemid 40470441)
16. W.N. Venables, and B.D. Ripley Modern applied statistics with S 4th ed. 2002 Springer New York
17. J. Nyman, K.A. Johansson, and U. Hultén Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer: Mature results for medically inoperable patients Lung Cancer 51 2006 97 103 (Pubitemid 43088629)
18. M. Hoyer, H. Roed, and A.T. Hansen Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 S128 S135
19. M. Koto, Y. Takai, and Y. Ogawa A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer Radiother Oncol 85 2007 429 434 (Pubitemid 350213143)
20. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase ii study Int J Radiat Oncol Biol Phys 75 2009 677 682
21. U. Ricardi, A.R. Filippi, and A. Guarneri Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial Lung Cancer 68 2010 72 77
22. N. Kopek, M. Paludan, and J. Petersen Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
23. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
24. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431 (Pubitemid 41628038)
25. T. Koike, R. Tsuchiya, and T. Goya Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan J Thorac Oncol 2 2007 408 413 (Pubitemid 47181695)
26. K. Kameyama, M. Takahashi, and K. Ohata Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution J Thorac Cardiovasc Surg 137 2009 1180 1184
27. E. Ruffini, P.L. Filosso, and M.C. Bruna Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: A validation study from a single-centre experience Eur J Cardiothorac Surg 36 2009 1037 1044
28. C. Ye, J.R. Masterman, and M.S. Huberman Subdivision of the T1 size descriptor for stage I non-small cell lung cancer has prognostic value: A single institution experience Chest 136 2009 710 715
29. E. Radzikowska, P. Głaz, and K. Roszkowski Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases Ann Oncol 13 2002 1087 1093
30. R. Moore, D. Doherty, and R. Chamberlain Sex differences in survival in non-small cell lung cancer patients 1974-1998 Acta Oncol 43 2004 57 64 (Pubitemid 38283174)
31. H. Minami, M. Yoshimura, and Y. Miyamoto Lung cancer in women: Sex-associated differences in survival of patients undergoing resection for lung cancer Chest 118 2000 1603 1609 (Pubitemid 32001783)
32. D. Ost, J. Goldberg, and L. Rolnitzky Survival after surgery in stage IA and IB non-small cell lung cancer Am J Respir Crit Care Med 177 2008 516 523 (Pubitemid 351442190)
33. S.L. McGovern, Z. Liao, and M.K. Bucci Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer 115 2009 3233 3242
34. M. Koukourakis, G. Hlouverakis, and L. Kosma The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma Int J Radiat Oncol Biol Phys 34 1996 315 322 (Pubitemid 26031576)
35. M. Chen, G.L. Jiang, and X.L. Fu The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer Lung Cancer 28 2000 11 19 (Pubitemid 30125834)
36. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
37. H. Kato, Y. Ichinose, and M. Ohta A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721 (Pubitemid 38501140)
38. G.M. Strauss, J.E. Herndon, and M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 26 2008 5043 5051